PlantFuel begins clinical trials on its Performance Protein vs Whey Protein. – PlantFuel Life Inc. (CSE: FUEL) (OTC: PLFLF) (FSE: BR1B) (“PlantFuel” or the “Company”) has […]
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant Therapy for Certain Patients With Renal Cell Carcino. – FDA Approves Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant Therapy for Certain […]
PlantFuel begins clinical trials on its Performance Protein vs Whey Protein. – PlantFuel Life Inc. (CSE: FUEL) (OTC: PLFLF) (FSE: BR1B) (“PlantFuel” or the “Company”) has […]
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant Therapy for Certain Patients With Renal Cell Carcino. – FDA Approves Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant Therapy for Certain […]